I-Mab to Hold Investor Call to Present In-depth Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins’s Lymphoma

I Mab To Hold Investor Call To Present In Depth Clinical Data Of Lemzoparlimab In Combination With Rituximab In Non Hodgkins's Lymphoma

Facebook Comments

Leave a Reply

CommentLuv badge